Mode
Text Size
Log in / Sign up

Antimicrobial stewardship bundle improved perioperative antibiotic protocol adherence in oncourology surgeries

Antimicrobial stewardship bundle improved perioperative antibiotic protocol adherence in oncourology…
Photo by Pharmacy Images / Unsplash
Key Takeaway
Consider AMS bundles for improving perioperative antibiotic protocol adherence, but note single-center observational limitations.

This retrospective observational study evaluated the effectiveness of an antimicrobial stewardship (AMS) strategy bundle in an oncourology department at a single Russian hospital. The study included 226 patients who underwent prostatectomy or nephrectomy, comparing outcomes before and after implementation of an AMS bundle that included pre-authorization, audit with feedback, education, and handshake stewardship with active clinical pharmacologist participation.

Implementation of the AMS bundle was associated with increased compliance with perioperative antibiotic prophylaxis protocols. For prostatectomies, compliance increased from 0% to 47.7%, while for nephrectomies it increased from 0% to 55.6%. The mean duration of antibiotic use decreased from 7 to 2 days (p<0.001), and overall antibiotic consumption decreased by 31.2%. Direct drug costs were reduced by a factor of 4.3, and the proportion of ESKAPE organisms in the microbial profile decreased from 26.3% to 16.4%.

Safety and tolerability data were not reported. The study's key limitation is its single-center retrospective observational design, which precludes causal conclusions and limits generalizability. Follow-up duration was also not reported. The authors suggest this approach could serve as a model for optimizing perioperative antibiotic prophylaxis in other surgical departments, but these findings should be interpreted as preliminary associations rather than established effects.

Study Details

Sample sizen = 125
EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Objective. To evaluate the effectiveness of a bundle of interventions involving a clinical pharmacologist aimed at changing surgeons approach to perioperative antibiotic prophylaxis (PAP) in an oncourology department. Materials and Methods. A single-center retrospective observational study was conducted. Data from 226 patients who underwent prostatectomy or nephrectomy in the oncourology department of Regional Clinical Hospital No. 2 (Krasnodar, Russia) between 2023 and 2025 were analyzed. Periods before (n=125) and after (n=101) the implementation of an Antimicrobial Stewardship (AMS) strategy bundle with active participation of a clinical pharmacologist (pre-authorization, audit with feedback, education, handshake stewardship) were compared. The primary endpoint was the proportion of surgeries performed in compliance with the PAP protocol. Secondary endpoints included the incidence of infectious complications, antibiotic consumption (DDD/100 bed-days), direct costs of antibacterial drugs, dynamics of the microbial landscape, and the Drug Resistance Index (DRI). Results. After AMS implementation, the proportion of surgeries performed in accordance with the PAP protocol increased from 0% to 47.7% for prostatectomies and to 55.6% for nephrectomies. The mean duration of antibiotic use decreased from 7 to 2 days (p<0.001). Antibiotic consumption decreased by 31.2%, and costs were reduced by a factor of 4.3. The proportion of ESKAPE organisms in the microbial profile decreased from 26.3% to 16.4%. There was no statistically significant increase in the frequency of infectious complications (2.4% vs. 3.0%; p=1.000) or mortality (0% in both groups). Conclusions. AMS implementation integrating a clinical pharmacologist into the oncourology department workflow significantly improved adherence to clinical guidelines, reduced irrational antibiotic use and financial costs without compromising patient safety. This approach can serve as a model for optimizing PAP in other surgical departments. Keywords: antibiotic prophylaxis, antimicrobial stewardship, drug resistance, clinical pharmacologist, cost-benefit analysis, oncourology
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.